Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Diagnostic performance of expression of PCA3, Hepsin and miR biomarkers inejaculate in combination with serum PSA for the detection of prostate cancer
- M. Roberts, Clement W. K. Chow, +10 authors R. Gardiner
- Medicine
- The Prostate
- 1 April 2015
Here, we report on the evaluation of the diagnostic performance of ejaculate‐derived PCA3, Hepsin, and miRNAs to complement serum PSA to detect prostate cancer. cDNA was prepared from 152 candidate… Expand
Phase II study of gemcitabine and oxaliplatin in patients with recurrent ovarian cancer: an Australian and New Zealand Gynaecological Oncology Group study
- P. Harnett, M. Buck, +8 authors R. Stuart-Harris
- Medicine
- International Journal of Gynecologic Cancer
- 3 August 2006
Gemcitabine and oxaliplatin have shown single-agent activity in relapsed ovarian cancer. This combination was used to determine response rates, time-to-event efficacy measures, and toxicity in… Expand
Identification of claudin-4 as a marker highly overexpressed in both primary and metastatic prostate cancer
- K. Landers, H. Samaratunga, +5 authors R. Gardiner
- Biology, Medicine
- British Journal of Cancer
- 22 July 2008
In the quest for markers of expression and progression for prostate cancer (PCa), the majority of studies have focussed on molecular data exclusively from primary tumours. Although expression in… Expand
Phase II trial of weekly docetaxel for patients with relapsed ovarian cancer who have previously received paclitaxel--ANZGOG 02-01.
- A. Tinker, V. Gebski, +5 authors D. Rischin
- Medicine
- Gynecologic oncology
- 1 March 2007
OBJECTIVE
To determine the response rate of weekly docetaxel in women with relapsed epithelial ovarian cancer previously treated with paclitaxel and at least one line of platinum-based chemotherapy.… Expand
BMCC1 Is an AP-2 Associated Endosomal Protein in Prostate Cancer Cells
- J. Harris, Renée S. Richards, +7 authors M. Lavin
- Biology, Medicine
- PloS one
- 6 September 2013
The prostate cancer antigen gene 3 (PCA3) is embedded in an intron of a second gene BMCC1 (Bcl2-/adenovirus E1B nineteen kDa-interacting protein 2 (BNIP-2) and Cdc42GAP homology BCH motif-containing… Expand
Phase II study of carboplatin followed by sequential gemcitabine and paclitaxel as first-line treatment for advanced ovarian cancer
- M. Friedlander, M. Buck, +8 authors P. Harnett
- Medicine
- International Journal of Gynecologic Cancer
- 11 September 2006
The aim of this exploratory phase II study was to evaluate sequential chemotherapy with carboplatin followed by gemcitabine–paclitaxel combination in chemonaive patients with advanced ovarian cancer.… Expand
Nonwoven Carboxylated Agarose-Based Fiber Meshes with Antimicrobial Properties.
- A. Forget, N. Arya, +6 authors V. Shastri
- Chemistry, Medicine
- Biomacromolecules
- 22 November 2016
Hydrogel forming polysaccharides, such as the seaweed derived agarose, are well suited for wound dressing applications as they have excellent cell and soft tissue compatibility. For wound dressings,… Expand
Elevated levels of Dickkopf-related protein 3 in seminal plasma of prostate cancer patients
- C. Zenzmaier, M. Heitz, H. Klocker, M. Buck, R. Gardiner, P. Berger
- Medicine
- Journal of Translational Medicine
- 10 November 2011
BackgroundExpression of Dkk-3, a secreted putative tumor suppressor, is altered in age-related proliferative disorders of the human prostate. We now investigated the suitability of Dkk-3 as a… Expand
Seminal plasma enables selection and monitoring of active surveillance candidates using nuclear magnetic resonance-based metabolomics: A preliminary investigation
- M. Roberts, Renée S. Richards, +5 authors R. Gardiner
- Medicine
- Prostate international
- 23 March 2017
Background Diagnosis and monitoring of localized prostate cancer requires discovery and validation of noninvasive biomarkers. Nuclear magnetic resonance (NMR)-based metabolomics of seminal plasma… Expand
Prostate-based biofluids for the detection of prostate cancer: A comparative study of the diagnostic performance of cell-sourced RNA biomarkers
- M. Roberts, Renée S. Richards, +9 authors R. Gardiner
- Medicine
- Prostate international
- 5 May 2016
Background Prostate cancer (PCa) diagnosis requires improvement with the aid of more accurate biomarkers. Postejaculate urethral washings (PEUW) could be a physiological equivalent to urine obtained… Expand
...
1
2
3
...